Search Results - "A Gabayan"

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MAGNETISMM-3 STUDY by M Mohty, M Tomasson, B Arnulf, N Bahlis, M Prince, R Niesvizky, P Rodrgue-Otero, J Martine-Lopez, G Koehne, Y Jethava, A Gabayan, D Stevens, A Nooka, N Raje, S Iida, E Leip, U Conte, A Czibere, A Viqueira, V Blunk, A Lesokhin

“…Introduction/Objectives: To report the findings of extended follow-up and biweekly administration of elranatamab monotherapy in patients (pts) with…”
Get full text

Abdominal Tuberculosis in Patients Infected with the Human Immunodeficiency Virus by Fee, Martin J., Oo, Maung M., Gabayan, Afshin E., Radin, D. Randall, Barnes, Peter F.

“…We compared the presentation of abdominal tuberculosis in 43 patients infected with the human immunodeficiency virus (HIV) and in 35 patients without HIV…”
Get full text

Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study by Mohty, Mohamad, Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Prince, H. Miles, Niesvizky, Ruben, Rodríguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Jethava, Yogesh, Gabayan, A. Eli, Stevens, Don A., Nooka, Ajay K., Raje, Noopur S., Iida, Shinsuke, Leip, Eric, Conte, Umberto, Czibere, Akos Gabor, Viqueira, Andrea, Lesokhin, Alexander M.

“…8039 Background: MagnetisMM-3 (NCT04649359) is an open-label, multicenter, registrational phase 2 study evaluating the efficacy and safety of elranatamab…”
Get full text

TRUST-II: A global phase II study for taletrectinib in ROS1 fusion–positive lung cancer and other solid tumors by Nagasaka, Misako, Sugawara, Shunichi, Choi, Chang-Min, Okamoto, Tatsuro, Yanagitani, Noriko, Nosaki, Kaname, Takahashi, Toshiaki, Fujiwara, Yutaka, Hayashi, Hidetoshi, Khoury, John, Nieva, Jorge J., Gabayan, A. Eli, Raez, Luis E., Chen, Hongbin, Dimou, Anastasios, Pennell, Nathan A., Liu, Geoffrey, Ou, Sai-Hong Ignatius, Seto, Takashi, Ohe, Yuichiro

“…TPS8601 Background: Taletrectinib (AB-106/DS-6051b) is a next-generation, brain-penetrant, ROS1/ NTRK tyrosine kinase inhibitor (TKI) and has shown clinically…”
Get full text

PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors by Vaena, Daniel A., Chaves, Jorge, Vogelzang, Nicholas J., Matrana, Marc Ryan, Gabayan, A. Eli, Riese, Matthew John, Cho, Daniel C., Tagliaferri, Mary Ann, Zalevsky, Jonathan, Xie, Sunny, Hoch, Ute, RIZWAN, AHSAN NAQI, Aung, Sandra, Imperiale, Michael, Schwarz, James K.

“…Abstract only…”
Get full text

A phase 1b/2 study of INCB039110 + nab-paclitaxel (N) and gemcitabine (G) in patients (pts) with advanced solid tumors and pancreatic cancer (PC) by Beatty, Gregory Lawrence, Shahda, Safi, Beck, J. Thaddeus, Uppal, Nikhil Premparkash, Cohen, Steven J., Donehower, Ross C., Gabayan, A. Eli, Assad, Albert, Switzky, Julie C., Zhen, Huiling, Von Hoff, Daniel D.

“…Abstract only 362 Background: JAK-STAT activity has been associated with malignant cell proliferation and production of proinflammatory cytokines involved in…”
Get full text

252 Gliasite radiotherapy boost as part of initial treatment of malignant gliomas: A multi-institutional analysis by Welsh, J., Gabayan, A., Sanan, A., Green, S., Haas, M., Burris, S., Bishop, M., Stea, B.

Get full text

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results by Lesokhin, Alexander M., Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Miles Prince, H., Niesvizky, Ruben, Rodrίguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Touzeau, Cyrille, Jethava, Yogesh, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Gabayan, Afshin Eli, Stevens, Don A., Nooka, Ajay K., Manier, Salomon, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Searle, Emma, Leip, Eric, Sullivan, Sharon T., Conte, Umberto, Elmeliegy, Mohamed, Czibere, Akos, Viqueira, Andrea, Mohty, Mohamad

“…Elranatamab is a humanized B-cell maturation antigen (BCMA)-CD3 bispecific antibody. In the ongoing phase 2 MagnetisMM-3 trial, patients with relapsed or…”
Get full text

Thrombolytic therapy vs angioplasty in acute myocardial infarction by Yee, Aynna, Gabayan, Arash, Carbajal, Enrique V

Get full text

GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas:A Retrospective Multi-institutional Analysis by Gabayan, Arash J., Green, Sylvan B., Sanan, Abhay, Jenrette, Joseph, Schultz, Christopher, Papagikos, Michael, Tatter, Stephen P., Patel, Ashish, Amin, Pradip, Lustig, Robert, Bastin, Kenneth T., Watson, Gordon, Burri, Stuart, Stea, Baldassarre

“…Abstract OBJECTIVE: To review the cumulative experience of 10 institutions in treating recurrent malignant gliomas with the brachytherapy device, GliaSite…”
Get full text

Thrombolytic Therapy vs Angioplasty in Acute Myocardial Infarction by Pechlaner, Christoph, Bellmann, Romuald

Get full text

The effect of anterior cruciate ligament graft rotation on knee laxity and graft tension: An in vitro biomechanical analysis by HAME, Sharon L, MARKOLF, Keith L, GABAYAN, Arash J, HUNTER, D. Monte, DAVIS, Brent, SHAPIRO, Matthew S

“…The purpose of this study was to determine the effects of rotating a bone-patellar tendon- bone allograft during anterior cruciate ligament reconstruction on…”
Get full text